InfoTechTarget and Informa Tech's Digital Businesses Combine.

Together, we power an unparalleled network of 220+ online properties covering 10,000+ granular topics, serving an audience of 50+ million professionals with original, objective content from trusted sources. We help you gain critical insights and make more informed decisions across your business priorities.

AI in preclinical research: How Bayer and Pfizer transform drug discovery

Presented by

Nimisha Asthagiri, Head of AI and Analytics at Thoughtworks; Sarang Kulkarni, Tech Pr. at TW; Jonas Münch, Head of Pharmacology & Safety IT, Bayer AG; Kate Ostbye, Dir. of Data Science & ML at Pfizer.

About this talk

Artificial intelligence is fundamentally reshaping the landscape of preclinical research and drug discovery. In this exclusive on-demand webinar, learn how industry leaders are leveraging AI-powered research assistants to accelerate innovation. Join experts from Bayer, Pfizer, and Thoughtworks as they explore how a Retrieval-Augmented Generation (RAG) methodology transforms knowledge management and research workflows. The Head of Pharmacology & Safety IT at Bayer AG and the Director of Data Science & Machine Learning at Pfizer will share their insights from real-world applications of AI for drug discovery. Key topics covered include: - Challenges and opportunities in optimizing knowledge retrieval, interpretation, and creation in preclinical R&D. - The technology and methodology behind AI-powered research assistants, including how RAG enables superior data-driven decisions. - Real-world case studies demonstrating how Bayer and Pfizer implemented these systems to address inefficiencies. - Practical applications of AI and RAG-based assistants to enhance collaboration and productivity within research teams. This session provides essential information for pharmaceutical R&D leaders, data scientists, and innovation strategists seeking to harness the capabilities of AI in preclinical research with AI. Watch now to understand how leading organizations are utilizing advanced AI to define the future of drug discovery.
Thoughtworks

Thoughtworks

380 subscribers27 talks
Design. Engineering. AI.
We are a global technology consultancy that delivers extraordinary impact by blending design, engineering and AI expertise. Our commitment to design-led thinking, engineering excellence and innovation means we prioritize people, build teams with strong technical foundations and embed AI into every step of the process – not just as a tool, but as a mindset. It’s this approach that sets us apart, sparks bold ideas and empowers us to drive real, lasting innovation. We’re not preparing for the future – we’re defining it.
Related topics